SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-064011
Filing Date
2015-02-26
Accepted
2015-02-26 07:09:34
Documents
3
Period of Report
2015-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d881437d8k.htm 8-K 14340
2 EX-99.1 d881437dex991.htm EX-99.1 60465
3 GRAPHIC g881437img01.jpg GRAPHIC 6869
  Complete submission text file 0001193125-15-064011.txt   85837
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 15650123
SIC: 2834 Pharmaceutical Preparations